RVPH
Reviva Pharmaceuticals Holdings Inc.

4,780
Mkt Cap
$53.27M
Volume
4.54M
52W High
$4.28
52W Low
$0.2522
PE Ratio
-0.85
RVPH Fundamentals
Price
$0.553
Prev Close
$0.5899
Open
$0.5709
50D MA
$0.497
Beta
0.58
Avg. Volume
18M
EPS (Annual)
-$0.9026
P/B
-81.93
Rev/Employee
$0.00
Loading...
Loading...
Reviva Pharmaceuticals Holdings, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of therapeutics for the central nervous system, respiratory, and metabolic diseases. It uses chemical genomics driven technology platform and proprietary chemistry to develop new medicines. It focuses on the RP5063 (Brilaroxazine) and RP1208 pipelines. The company was founded by Laxminarayan Bhat on December 11, 2020 and is headquartered in Cupertino, CA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
14

Frequently Asked Questions

What is Market Cap of Reviva Pharmaceuticals Holdings Inc.?
What is the 52-week high for Reviva Pharmaceuticals Holdings Inc.?
What is the 52-week low for Reviva Pharmaceuticals Holdings Inc.?
What is Reviva Pharmaceuticals Holdings Inc. stock price today?
What was Reviva Pharmaceuticals Holdings Inc. stock price yesterday?
What is the PE ratio of Reviva Pharmaceuticals Holdings Inc.?
What is the Price-to-Book ratio of Reviva Pharmaceuticals Holdings Inc.?
What is the 50-day moving average of Reviva Pharmaceuticals Holdings Inc.?
How many employess does Reviva Pharmaceuticals Holdings Inc. has?

Latest RVPH News

View

Advertisement|Remove ads.

Advertisement|Remove ads.